Chemoinformaics analysis of 11-Methoxyerythraline
| Molecular Weight | 343.423 | nRot | 2 |
| Heavy Atom Molecular Weight | 318.223 | nRig | 24 |
| Exact Molecular Weight | 343.178 | nRing | 5 |
| Solubility: LogS | -3.183 | nHRing | 3 |
| Solubility: LogP | 3.351 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 54.3778 |
| nHD | 0 | BPOL | 33.7342 |
| QED | 0.772 |
| Synth | 5.006 |
| Natural Product Likeliness | 2.004 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.995 |
| Pgp-sub | 0.466 |
| HIA | 0.002 |
| CACO-2 | -4.748 |
| MDCK | 0.0000209 |
| BBB | 0.993 |
| PPB | 0.912644 |
| VDSS | 2.691 |
| FU | 0.0184607 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.722 |
| CYP2c19-inh | 0.071 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.177 |
| CYP2c9-sub | 0.384 |
| CYP2d6-inh | 0.587 |
| CYP2d6-sub | 0.435 |
| CYP3a4-inh | 0.928 |
| CYP3a4-sub | 0.93 |
| CL | 12.334 |
| T12 | 0.214 |
| hERG | 0.28 |
| Ames | 0.936 |
| ROA | 0.502 |
| SkinSen | 0.048 |
| Carcinogencity | 0.51 |
| EI | 0.01 |
| Respiratory | 0.915 |
| NR-Aromatase | 0.435 |
| Antiviral | No |
| Prediction | 0.635454 |